misrepresentation

Law firm Bernstein Liebhard announces class action against $NKTR over alleged misrepresentations regarding Phase 2b trial results, affecting investors from February to December 2025.

NuScale shareholders sue Fluor over $495M ENTRA1 payment that preceded 70% stock collapse, alleging inadequate board oversight of misrepresentations.

Ardent Health faces securities lawsuit over accounting practices; investors with $100K+ losses urged to seek counsel before March 9, 2026 deadline.

uniQure faces securities lawsuit for allegedly misrepresenting Huntington's study design approval and downplaying BLA delays. Investors must act by April 13, 2026.

CoreWeave faces securities lawsuit over data center delays; stock plunged 16% in November. Investors have until March 13, 2026, to join class action.

$PLUG faces securities fraud suit alleging misrepresentation of $1.66B DOE loan access. Stock fell 17% after loan program suspension; investors have until April 3, 2026 to join.

NuScale faces securities class action over alleged ENTRA1 misrepresentation. Stock fell 12.4% after $495M payment disclosure. April 20 deadline to join.

Rosen Law Firm files class action against Apollo Global Management ($APO) alleging executives concealed Epstein ties; investors urged to act before deadline.

NuScale Power faces securities class action over alleged material misstatements regarding ENTRA1 partnership qualifications. Shareholders have until April 20, 2026 to register.

Class action lawsuit filed against $BSX over alleged misrepresentations in U.S. electrophysiology segment between July 2025 and February 2026.

uniQure faces securities class action lawsuit alleging misstatements about Pivotal Study design and FDA approval. Lead plaintiff deadline: April 13, 2026.

Ramaco Resources faces class action securities fraud lawsuit over alleged misrepresentation of Wyoming Brook Mine operations; eligible shareholders must file claims by March 31, 2026.

Rosen Law Firm files securities class action against Ardent Health for alleged misrepresentations in accounts receivable and insurance reserves. March 9 deadline for lead plaintiff claims.

Levi & Korsinsky files class action against Inovio Pharmaceuticals alleging management misrepresented FDA accelerated approval eligibility for lead candidate, causing stock decline.

Rosen Law Firm urges Masonite ($DOOR) investors who sold shares June 2023-February 2024 to join securities class action before April 7, 2026 deadline, alleging undisclosed acquisition information.

uniQure faces securities class action over alleged misrepresentations regarding FDA approval status of Huntington's Disease trial design and regulatory timeline delays. Lead plaintiff deadline April 13, 2026.

CoreWeave investors have until March 13, 2026, to join securities fraud class action alleging misrepresented demand and concealed construction delays that triggered 16% stock decline.

Bleichmar Fonti & Auld files securities fraud class action against Ardent Health after 33% stock plunge following $43M revenue decline disclosure. Deadline March 9.

Plug Power faces securities fraud suit over DOE loan misrepresentations; investors have until April 3, 2026 to join class action after 17% stock decline.

NuScale Power faces securities fraud lawsuit over misrepresentations about ENTRA1 partner capabilities. Stock declined 12.4% after $495 million payment disclosure. Investors have until April 20, 2026 to join class action.